Journals / Türk Biyokimya Dergisi / 2007 / Cilt: 32 - Sayı: 2

The effect of steroid treatment on serum Oxidant-antioxidant system and cytokine levels in childhood asthma

Çocukluk çağı astımında steroid tedavisinin serum Oksidan-antioksidan sistem ve sitokin düzeylerine etkisi

Pages
55–60
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we observed that budenoside treatment in mild to moderate stable asthmatic children had no direct effect on oxidant stress, antioxidant defense, interleukin-6 and tumor necrosis factor-α.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to investigate the plasma levels of interleukin-6, tumor necrosis factor-α, immunoglobulin E, eosinophil cationic protein, thiobarbituric acid reactive substance and total antioxidant status which were suggested to have a significant role in the pathogenesis of asthma in children and to evaluate the effect of steroid on these parameters. 27 children, mean aged 8.9 years with mild-moderate persistent asthma for the study group and 25 healthy children, mean aged 10.3 years for the control group are included in the study group.
📊
Key Findings & Data:The symptom score, respiratory function test, plasma immunoglobulin E, eosinophil cationic protein, interleukin-6, tumor necrosis factor-α, thiobarbituric acid reactive substance and total antioxidant status levels were measured in the study group before and 4 weeks after budenoside treatment and compared with the control group.
💡
Conclusion & Impact:In conclusion, we observed that budenoside treatment in mild to moderate stable asthmatic children had no direct effect on oxidant stress, antioxidant defense, interleukin-6 and tumor necrosis factor-α.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to investigate the plasma levels of interleukin-6, tumor necrosis factor-α, immunoglobulin E, eosinophil cationic protein, thiobarbituric acid reactive substance and total antioxidant status which were suggested to have a significant role in the pathogenesis of asthma in children and to evaluate the effect of steroid on these parameters. 27 children, mean aged 8.9 years with mild-moderate persistent asthma for the study group and 25 healthy children, mean aged 10.3 years for the control group are included in the study group. The symptom score, respiratory function test, plasma immunoglobulin E, eosinophil cationic protein, interleukin-6, tumor necrosis factor-α, thiobarbituric acid reactive substance and total antioxidant status levels were measured in the study group before and 4 weeks after budenoside treatment and compared with the control group. The tumor necrosis factor-α, thiobarbituric acid reactive substance, immunoglobulin E and eosinophil cationic protein levels measured before treatment were significantly higher than those of the control group. Although a significant decrease was observed in thiobarbituric acid reactive substance, eosinophil cationic protein and immunoglobulin E levels after inhaled steroid treatment, the interleukin-6, tumor necrosis factor-α and total antioxidant status levels showed no difference. The tumor necrosis factor-α, immunoglobulin E and eosinophil cationic protein levels after treatment were significantly higher than those of the control group. In conclusion, we observed that budenoside treatment in mild to moderate stable asthmatic children had no direct effect on oxidant stress, antioxidant defense, interleukin-6 and tumor necrosis factor-α. These results lead us to the decision that the steroidal treatment may achieve a clinical improvement mainly by decreasing the levels of immunoglobulin E and eosinophil cationic protein.

Özet

Bu çalışmanın amacı, çocuklardaki astım oluşumunda önemli bir role sahip olduğu düşünülen interlökin-6, tümör nekrozis faktör-α, immünglobulin E, eozinofilik katyonik protein, tiyobarbitürik asid ile reaksiyona giren maddeler ile total antioksidan serum düzeylerini ve steroid tedavisinin bu parametrelere etkisini değerlendirmekti. Çalışma grubuna yaş ortalaması 8.9 olan 27 hafif-orta süreğen astımlı ve kontrol grubuna da yaş ortalaması 9.2 olan 25 sağlıklı çocuk dahil edildi. Semptom puanlaması, solunum fonksiyon testi, serum immünglobulin E, eozinofilik katyonik protein, interlökin-6, tümör nekrozis faktör-α, tiyobarbitürik asid ile reaksiyona giren maddeler ve total antioksidan düzeyleri astımlı hasta grupta tedavi öncesi ve 4 haftalık budenozid tedavisin sonrası ölçüldü ve sağlıklı grubun sonuçlarıyla karşılaştırıldı. Tedavi öncesi tümör nekrozis faktör-α, tiyobarbitürik asid ile reaksiyona giren maddeler, immünglobulin E ve eozinofilik katyonik protein düzeylerinin kontrol grubundan istatistiksel olarak anlamlı yüksek olduğu saptandı. Solunum yoluyla kullanılan steroid tedavisi ile tiyobarbitürik asid ile reaksiyona giren maddeler, eozinofilik katyonik protein ve immünglobulin E derişimlerinde anlamlı bir azalma belirlenirken interlökin-6, tümör nekrozis faktör-α ve total antioksidan status düzeylerinde anlamlı bir değişiklik saptanmadı. Tedavi sonrası tümör nekrozis faktör-α, immünglobulin E ve eozinofilik katyonik protein düzeyleri kontrol grubundan anlamlı olarak yüksek bulundu. Sonuç olarak, hafif-orta süreğen kararlı astımlı çocuklarda budenozid tedavisinin oksidan stres, antioksidan savunma ve öncül yangısal sitokinlerden interlökin-6 ve tümör nekrozis faktör-α üzerine direkt etkisi olmadığı gözlendi. Bu hastalarda elde ettiğimiz sonuçlar, steroid tedavisinin esas olarak immünglobulin E ve eozinofilik katyonik protein düzeylerini azaltarak klinik düzelmeyi sağladığını düşündürtmektedir.

🔖

Cite This Article

CAN, M., GÜVEN, B., DEMİRTAŞ, S., YÜKSEL, B., MUNGAN, A. G., TUNCER, T., ÜSTÜNDAĞ, H. G., TOMAÇ, N. (2022). The effect of steroid treatment on serum Oxidant-antioxidant system and cytokine levels in childhood asthma. Türk Biyokimya Dergisi, Cilt: 32 - Sayı: 2, 55–60. https://ajindex.com/articles/621393

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW. (2005) The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis. 9 (1): 10-6
  2. Georgitis JW. (1999) The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. National Heart, Lung, and Blood Institute. Chest. 115 (1): 210-7
  3. Balzar S, Strand M, Rhodes D, Wenzel SE. (2007) IgE expression pattern in lung: Relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol. 119 (4): 855-62
  4. Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD. (2005) The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 60: 302–8
  5. Henry JB. (2001) Allergic Diseases. Clinical Diagnosis and Management by Laboratory Methods Book, s.1016-1027, Oxford University Press, New York
  6. Gerard JW, Blumenthal MN. (1993) Genetic factors. Bronchial Asthma, s.26-31, Little Brown Comp, Boston
  7. Mastorakos G, Ilias I. (2006) Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress. Ann N Y Acad Sci. 1088: 373-81
  8. Okahashi N, Yamamoto M, Vancott JL, Chatfield SN, Roberts M, Bluethmann H, Hiroi T, Kiyono H, McGhee JR. (1996) Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun. 64: 1516-25
  9. Mukhopadhyay S, Hoidal JR, Mukherjee TK. (2006) Role of TNF alpha in pulmonary pathophysiology. Respir Res.11,117-25
  10. Leung TF, Wong GW, Ko FW, Lam CW, Fok TF. (2005) Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis. Thorax.60 (10): 822-6
  11. Weller P. (1984) Eosinophilia. J Allergy Clin Immunol. 73: 1–10
  12. Wolthers OD. (2003) Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol. 14 (4): 248-54
  13. Niimi A, Matsumoto H. (1999) Serum measurement of eosinophil cationic protein in the management of asthma. Curr Opin Pulm Med. 5 (2): 111-7
  14. Young JD, Peterson CG, Venge P, Cohn ZA. (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 321: 613-6. [15 ] Barnes PJ. (1990) Reactive